Morgan Stanley
ONCR

Morgan Stanley’s Oncorus, Inc. ONCR Stock Holding History

Morgan Stanley’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,506
Closed -$1.55K – 7756
2023
Q1 		$1.55K Sell
4,506
-3,888
-46% -$1.45K ﹤0.01% 7284
2022
Q4 		$2.13K Sell
8,394
-6,995
-45% -$3.98K ﹤0.01% 7358
2022
Q3 		$13K Sell
15,389
-28,109
-65% -$36.1K ﹤0.01% 6993
2022
Q2 		$55K Sell
43,498
-37,312
-46% -$50.7K ﹤0.01% 6572
2022
Q1 		$143K Sell
80,810
-34,952
-30% -$97.9K ﹤0.01% 6105
2021
Q4 		$611K Buy
115,762
+38,565
+50% +$299K ﹤0.01% 5423
2021
Q3 		$721K Buy
77,197
+67,511
+697% +$770K ﹤0.01% 5278
2021
Q2 		$134K Sell
9,686
-183,212
-95% -$2.83M ﹤0.01% 6211
2021
Q1 		$2.69M Buy
192,898
+185,768
+2,605% +$3.85M ﹤0.01% 4026
2020
Q4 		$230K Buy
+7,130
New +$165K ﹤0.01% 5526

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Morgan Stanley's ONCR Position: Q2 2023 in Review

Morgan Stanley sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 4,506 shares — an estimated $1.55K sold.

Morgan Stanley first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $2.69M in Q1 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Morgan Stanley reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 4,506 Oncorus, Inc. shares in Q2 2023, an estimated $1.55K.
  • Morgan Stanley first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
  • Morgan Stanley's Oncorus, Inc. position peaked at $2.69M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.